Navigation Links
Wyeth Declares Preferred Stock Dividend
Date:11/20/2008

MADISON, N.J., Nov. 20 /PRNewswire-FirstCall/ -- At a meeting of the Board of Directors of Wyeth (NYSE: WYE), held today, a dividend of fifty cents($0.50) per share on the outstanding shares of Preferred Stock was declared payable on January 2, 2009 to stockholders of record at the close of business on December 12, 2008.

Wyeth is one of the world's largest research-driven pharmaceutical and health care products companies. It is a leader in the discovery, development, manufacturing and marketing of pharmaceuticals, vaccines, biotechnology products, nutritionals and non-prescription medicines that improve the quality of life for people worldwide. The Company's major divisions include Wyeth Pharmaceuticals, Wyeth Consumer Healthcare and Fort Dodge Animal Health.


'/>"/>
SOURCE Wyeth
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related biology technology :

1. Wyeth Reports Earnings Results for the 2008 Third Quarter and First Nine Months
2. Wyeth Wins Philadelphia Diet Drug Trial Involving Claim of PPH
3. Wyeth Announces Increase in Common Stock Dividend
4. Retrospective Analysis of Phase 3 Data Suggest Wyeths Investigational Compound Bazedoxifene/Conjugated Estrogens Comparable to Placebo on Incidence of Abnormal Mammograms
5. Wyeth Sets Webcast And Conference Call for 2008 Third Quarter Earnings
6. Cyprus and Ireland Add Wyeths 7-Valent Pneumococcal Conjugate Vaccine (PCV7) to Their National Immunisation Schedules
7. Wyeth Names Daniel J. McIntyre Vice President, Corporate Communications
8. Wyeth and Impax Announce Final Settlement of Effexor XR Patent Suit
9. Wyeths Motion to Overturn Punitive Damages Award Granted by Arkansas Court
10. Wyeth Announces Bernard Poussot Assumes Chairman of the Board Position
11. Wyeth Declares Common and Preferred Stock Dividends
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/25/2017)... , Sept. 25, 2017  Renova™ Therapeutics, a biotechnology ... metabolic diseases, announced that the company,s CEO and Co-founder, ... a panel at the Cell & Gene Therapy ... and its Vice President of Preclinical Research and Pharmacology, ... Boulder Peptide Symposium in Boulder, ...
(Date:9/25/2017)... ... September 25, 2017 , ... ... be presenting multiple case studies, presentations and demonstrations at SCDM 2017, held ... data managers, medical review teams and CRO partners for more automated capabilities ...
(Date:9/22/2017)... ... September 22, 2017 , ... Precision Periodontics and Implant Dentistry's ... LAPIP™ laser treatments. Drs. Hoge and Zalewsky are members of an elite class ... less painful option that produces real results. , "Like many of my colleagues, ...
(Date:9/21/2017)... ... 21, 2017 , ... Vixiar Medical announced today that it ... to The LaunchPort™ Accelerator at the City Garage in Port Covington. The LaunchPort™, ... business services to its Residents. , Vixiar Medical recently closed a $1.5 ...
Breaking Biology Technology:
(Date:4/5/2017)... Allen Institute for Cell Science today announces the launch ... dynamic digital window into the human cell. The website ... deep learning to create predictive models of cell organization, ... suite of powerful tools. The Allen Cell Explorer will ... resources created and shared by the Allen Institute for ...
(Date:4/3/2017)... 3, 2017  Data captured by IsoCode, ... detected a statistically significant association between the ... treatment and objective response of cancer patients ... predict whether cancer patients will respond to ... well as to improve both pre-infusion potency testing ...
(Date:3/29/2017)... , March 29, 2017  higi, the health IT ... North America , today announced a ... the acquisition of EveryMove. The new investment and acquisition ... of tools to transform population health activities through the ... data. higi collects and secures data today ...
Breaking Biology News(10 mins):